Prioritising the first COVID-19 vaccine dose: JCVI statement
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about increasing the short-term impact of the COVID-19 vaccination programme.
Documents
Optimising the COVID-19 vaccination programme for maximum short-term impactAnnex A: PHE report to JCVI on estimated efficacy of a single dose of Pfizer BioNTech (BNT162b2 mRNA) vaccine and of a single dose of ChAdOx1 vaccine (AZD1222)application/pdfAnnex B: comparison between 1 and 2 dose prioritisation for a fixed number of dosesapplication/pdf